Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.
Digital tools are becoming increasingly important across veterinary medicine, from clinical workflows to client communication and practice operations.
According to the announcement, Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing. The development is relevant because it reflects how animal health companies, service providers, and technology platforms are responding to changing expectations in veterinary care.
What Was Announced
Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, is pleased to announce that it has received its State of Washington Radioactive Materials License for the manufacturing of IsoPet ® . This approval represents a significant regulatory milestone for the Company’s animal health division.
It clears the way for in-house production of IsoPet ® at Vivos’ new domestic manufacturing facility located at the Applied Process Engineering Laboratory (APEL) in Richland, Washington. This is a critical step forward in our efforts to scale production and meet the growing demand from veterinarians and pet owners across the country for our innovative, same-day cancer therapy for animals.” Now that the IsoPet Radioactive Materials License has been granted, Vivos will immediately apply for an amendment to add RadioGel ® to the license.
Why This Matters for Veterinary Professionals
For veterinary professionals, technology announcements matter when they affect efficiency, access to care, diagnostics, reimbursement, or the daily workflow of the clinic.
At the practice level, the most relevant question is whether the development can reduce administrative friction, improve access to information, or support more consistent communication between veterinary teams and clients.
Industry Perspective
The animal health industry continues to move toward more connected, data-driven services for veterinary practices and pet owners.
While individual announcements should be interpreted in the context of their source, they can help veterinary professionals monitor where investment, innovation, and market attention are moving across the animal health sector.
Original announcement: Vivos Inc. — https://www.globenewswire.com/news-release/2026/06/11/3310458/0/en/vivos-inc-announces-receipt-of-washington-state-radioactive-materials-license-for-isopet-manufacturing.html
Comments
Related Articles
Copyright © 2026 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment